You can buy or sell ResTORbio and other stocks, options, ETFs, and crypto commission-free!
resTORbio, Inc. Common Stock, also called ResTORbio, is a clinical-stage biopharmaceutical company. Read More The firm engages in the development and commercialization of medicines for aging-related diseases and conditions. It offers an immunotherapy under the TORC1 program. The company was founded by Chen Schor and Joan Mannick on July 5, 2016 and is headquartered in Boston, MA.
52 Week High
52 Week Low
— per share
Expected May 14, Pre-Market